CheckMyRecalls

Zydus Pharmaceuticals (USA) Inc recalls Entecavir Tablets

Published
8 Oct 2025
Units affected
2 products
Agency
FDA
Country
United States

The hazard

Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.

Entecavir Tablets, USP, 1 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06.

Brand / company
Zydus Pharmaceuticals (USA) Inc
Codes / lots
Lot#: E409308, Exp 12/31/2026 | Lot#: E409309, Exp 12/31/2026
Distribution
Distributed Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 8 Oct 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.